JP7808465B2 - Organic compounds, reagents, and analytical methods - Google Patents
Organic compounds, reagents, and analytical methodsInfo
- Publication number
- JP7808465B2 JP7808465B2 JP2021205820A JP2021205820A JP7808465B2 JP 7808465 B2 JP7808465 B2 JP 7808465B2 JP 2021205820 A JP2021205820 A JP 2021205820A JP 2021205820 A JP2021205820 A JP 2021205820A JP 7808465 B2 JP7808465 B2 JP 7808465B2
- Authority
- JP
- Japan
- Prior art keywords
- organic compound
- group
- analytical method
- hydrocarbon group
- chemical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
本発明は、微量の化学物質を測定するための有機化合物、前記有機化合物を含有する試薬、及び前記有機化合物又は前記試薬を用いた分析方法に関する。 The present invention relates to an organic compound for measuring trace amounts of chemical substances, a reagent containing the organic compound, and an analytical method using the organic compound or the reagent.
医薬品や化粧品など人に接触する製品では、実際の使用条件においてアレルギー反応を引き起こさないことが重要である。そのため、製品開発においては配合する原料の皮膚感作性リスクを評価する必要がある。皮膚感作性は、動物実験であるGuinea Pig Maximization Test、Buehler Test、Local Lymph Node Assayなどにより評価されてきた。 It is important that products that come into contact with humans, such as pharmaceuticals and cosmetics, do not cause allergic reactions under actual conditions of use. Therefore, during product development, it is necessary to evaluate the risk of skin sensitization of the ingredients used. Skin sensitization has been evaluated using animal tests such as the Guinea Pig Maximization Test, Buehler Test, and Local Lymph Node Assay.
近年では、動物を用いることなく、in-vitroで化学物質の皮膚感作性を評価する代替法試験が開発されており、システインペプチドやリジンペプチド(非特許文献1)およびアミノ酸誘導体を用いた皮膚感作試験などが提案されている(特許文献1、2)。 In recent years, alternative tests have been developed to evaluate the skin sensitization potential of chemicals in vitro without using animals, and skin sensitization tests using cysteine peptides, lysine peptides (Non-Patent Document 1) and amino acid derivatives have been proposed (Patent Documents 1 and 2).
動物福祉の観点から動物実験は避けるべきであり、動物を用いない代替法試験による皮膚感作性評価を実現する必要がある。上記の代替法試験は簡便かつ迅速な方法で被験物質中に含まれる主成分の皮膚感作性を測定できる良い手法であるものの、微量不純物が原因となる皮膚感作性リスクを正しく評価できない懸念がある。システインペプチドやリジンペプチド(非特許文献1)及びアミノ酸誘導体を用いた皮膚感作試験(特許文献1、2)では、高感度な質量分析法を用いたとしても、得られる微量結合物の検出感度に問題があることが判明した。 From the perspective of animal welfare, animal testing should be avoided, and it is necessary to realize skin sensitization assessment using alternative methods that do not use animals. While the above-mentioned alternative tests are good methods that can measure the skin sensitization potential of the main components contained in test substances in a simple and rapid manner, there are concerns that they may not properly evaluate the risk of skin sensitization caused by trace impurities. In skin sensitization tests using cysteine peptides, lysine peptides (Non-Patent Document 1) and amino acid derivatives (Patent Documents 1 and 2), it was found that there were problems with the detection sensitivity of the resulting trace amounts of bound substances, even when highly sensitive mass spectrometry was used.
本発明の目的は、微量の化学物質(被験物質)を簡便、迅速かつ正確に測定するための有機化合物、前記有機化合物を含有する試薬、及び前記有機化合物又は前記試薬を用いた分析方法を提供することである。 The object of the present invention is to provide an organic compound for easily, quickly, and accurately measuring trace amounts of chemical substances (test substances), a reagent containing the organic compound, and an analytical method using the organic compound or the reagent.
本発明者等は、上記課題を解決するために鋭意研究した結果、皮膚感作性物質などの化学物質を特定の構造を有する標識試薬により標識し、しかる後に標識された化学物質を分析に供することにより、微量の化学物質を簡便、選択的かつ高感度に分析できることを見出し、本発明を完成するに到った。 As a result of intensive research conducted by the inventors to solve the above-mentioned problems, they discovered that trace amounts of chemical substances can be analyzed easily, selectively, and with high sensitivity by labeling chemical substances such as skin sensitizers with a labeling reagent having a specific structure and then subjecting the labeled chemical substances to analysis, leading to the completion of the present invention.
すなわち、本発明は、下記化学式(1)で表される有機化合物に関する。
また、本発明は、前記有機化合物を含有する試薬に関する。 The present invention also relates to a reagent containing the organic compound.
さらに、本発明は、前記有機化合物と、化学物質と、を反応させて反応物を得た後、前記反応物を分離し、検出する、分析方法に関する。 Furthermore, the present invention relates to an analytical method in which the organic compound is reacted with a chemical substance to obtain a reaction product, and then the reaction product is separated and detected.
本発明の有機化合物は、微量の化学物質(皮膚感作性物質など)に対して反応性が高い官能基(チオール基又はアミノ基)と、反応物の高感度検出を可能にする官能基(第四級アンモニウム基)と、反応物の高選択検出を可能にする官能基(ヘテロ原子と炭素原子との単結合を含む官能基)とを有しているため、汎用の分析方法及び分析装置を用いて、微量の化学物質を簡便、迅速かつ正確に測定することができる。本発明の有機化合物、試薬、及び分析方法は、例えば、微量の化学物質の皮膚感作性評価、及び微量の化学物質の定量的測定に用いることができる。 The organic compound of the present invention has a functional group (thiol group or amino group) that is highly reactive to trace amounts of chemicals (such as skin sensitizers), a functional group (quaternary ammonium group) that enables highly sensitive detection of the reactant, and a functional group (functional group containing a single bond between a heteroatom and a carbon atom) that enables highly selective detection of the reactant. Therefore, trace amounts of chemicals can be measured simply, quickly, and accurately using general-purpose analytical methods and analytical equipment. The organic compound, reagent, and analytical method of the present invention can be used, for example, to evaluate the skin sensitization potential of trace amounts of chemicals and to quantitatively measure trace amounts of chemicals.
以下、本発明について詳細に説明する。 The present invention is described in detail below.
<有機化合物>
本発明の有機化合物は、下記化学式(1)で表される。
The organic compound of the present invention is represented by the following chemical formula (1).
Xは、チオール基又はアミノ基であり、皮膚感作性物質などの化学物質(例えば、α,β-不飽和ケトン、酸無水物、及びアルデヒドなど)に対して反応性を有する官能基である。 X is a thiol group or an amino group, a functional group that is reactive with chemicals such as skin sensitizers (e.g., α,β-unsaturated ketones, acid anhydrides, and aldehydes).
R1、R2、R3、R4、及びR5は、それぞれ独立に炭化水素基であり、前記炭化水素基としては、直鎖状又は分岐鎖状の脂肪族飽和又は不飽和炭化水素基、脂環式飽和又は不飽和炭化水素基(橋かけ環、縮合環を含む)、芳香族炭化水素基、及びこれらの2種以上が結合した有機基などが挙げられる。また、前記炭化水素基は、本発明の効果を妨げない限り、種々の置換基を有していてもよい。 R1 , R2 , R3 , R4 , and R5 are each independently a hydrocarbon group, and examples of the hydrocarbon group include a linear or branched aliphatic saturated or unsaturated hydrocarbon group, an alicyclic saturated or unsaturated hydrocarbon group (including a bridged ring or a fused ring), an aromatic hydrocarbon group, and an organic group in which two or more of these are bonded together. The hydrocarbon group may have various substituents as long as they do not impede the effects of the present invention.
R1は、分析装置による検出を容易にする観点から、好ましくは置換基を有さない炭化水素基、より好ましくは直鎖状又は分岐鎖状の脂肪族飽和炭化水素基、更に好ましくは直鎖状の脂肪族飽和炭化水素基である。 From the viewpoint of facilitating detection by an analytical device, R1 is preferably a hydrocarbon group having no substituent, more preferably a linear or branched saturated aliphatic hydrocarbon group, and even more preferably a linear saturated aliphatic hydrocarbon group.
R2は、分析装置による検出を容易にする観点から、好ましくは置換基を有さない炭化水素基、より好ましくは芳香族炭化水素基、更に好ましくはフェニレン基である。 From the viewpoint of facilitating detection by an analytical device, R2 is preferably a hydrocarbon group having no substituent, more preferably an aromatic hydrocarbon group, and even more preferably a phenylene group.
R1、及びR2における炭化水素基の炭素数(ただし、置換基の炭素数は含まない。)は特に制限されないが、分析装置による検出を容易にする観点から、直鎖状の脂肪族飽和炭化水素基である場合には、1以上、好ましくは2以上であり、また、好ましくは12以下、より好ましくは8以下であり、直鎖状の不飽和炭化水素基である場合には、2以上、好ましくは3以上であり、また、好ましくは12以下、より好ましくは8以下であり、分岐鎖状の脂肪族飽和又は不飽和炭化水素基である場合には、3以上、好ましくは4以上であり、また、好ましくは12以下、より好ましくは8以下であり、脂環式飽和又は不飽和炭化水素基、あるいは芳香族炭化水素基である場合には、好ましくは6以上、また、好ましくは14以下、より好ましくは10以下である。 The number of carbon atoms in the hydrocarbon groups in R 1 and R 2 (not including the number of carbon atoms in the substituents) is not particularly limited, but from the viewpoint of facilitating detection by an analytical device, in the case of a linear aliphatic saturated hydrocarbon group, it is 1 or more, preferably 2 or more, and preferably 12 or less, more preferably 8 or less; in the case of a linear unsaturated hydrocarbon group, it is 2 or more, preferably 3 or more, and preferably 12 or less, more preferably 8 or less; in the case of a branched aliphatic saturated or unsaturated hydrocarbon group, it is 3 or more, preferably 4 or more, and preferably 12 or less, more preferably 8 or less; and in the case of an alicyclic saturated or unsaturated hydrocarbon group or an aromatic hydrocarbon group, it is preferably 6 or more, and preferably 14 or less, more preferably 10 or less.
R3、R4、及びR5は、分析装置による検出を容易にする観点から、好ましくは置換基を有さない炭化水素基、より好ましくは直鎖状又は分岐鎖状の脂肪族飽和炭化水素基、更に好ましくは直鎖状の脂肪族飽和炭化水素基である。 From the viewpoint of facilitating detection by an analytical device, R3 , R4 , and R5 are preferably unsubstituted hydrocarbon groups, more preferably linear or branched saturated aliphatic hydrocarbon groups, and even more preferably linear saturated aliphatic hydrocarbon groups.
R3、R4、及びR5における炭化水素基の炭素数(ただし、置換基の炭素数は含まない。)は特に制限されないが、分析装置による検出を容易にする観点から、直鎖状の脂肪族飽和炭化水素基である場合には、1以上、好ましくは2以上であり、また、好ましくは12以下、より好ましくは6以下であり、直鎖状の不飽和炭化水素基である場合には、2以上、好ましくは3以上であり、また、好ましくは12以下、より好ましくは6以下であり、分岐鎖状の脂肪族飽和又は不飽和炭化水素基である場合には、3以上、好ましくは4以上であり、また、好ましくは12以下、より好ましくは6以下であり、脂環式飽和又は不飽和炭化水素基、あるいは芳香族炭化水素基である場合には、好ましくは6以上、また、好ましくは14以下、より好ましくは10以下である。 The number of carbon atoms in the hydrocarbon groups in R3 , R4 , and R5 (not including the number of carbon atoms in substituents) is not particularly limited, but from the viewpoint of facilitating detection by an analytical device, in the case of a linear aliphatic saturated hydrocarbon group, it is 1 or more, preferably 2 or more, and preferably 12 or less, more preferably 6 or less; in the case of a linear unsaturated hydrocarbon group, it is 2 or more, preferably 3 or more, and preferably 12 or less, more preferably 6 or less; in the case of a branched aliphatic saturated or unsaturated hydrocarbon group, it is 3 or more, preferably 4 or more, and preferably 12 or less, more preferably 6 or less; and in the case of an alicyclic saturated or unsaturated hydrocarbon group or an aromatic hydrocarbon group, it is preferably 6 or more, and preferably 14 or less, more preferably 10 or less.
Aは、ヘテロ原子と炭素原子との単結合を含む官能基であり、加熱等によって前記単結合が開裂する官能基である。当該官能基を導入することにより、前記有機化合物由来のフラグメントイオンを検出することができ、極めて選択性が高く、高感度な分析が可能になる。前記官能基としては、例えば、アミド結合、エステル結合、エーテル結合、ウレタン結合、及びウレア結合などが挙げられる。前記官能基は、反応物の高選択検出の観点から、好ましくはアミド結合である。 A is a functional group containing a single bond between a heteroatom and a carbon atom, and the single bond is cleaved by heating or other means. Introducing this functional group makes it possible to detect fragment ions derived from the organic compound, enabling highly selective and sensitive analysis. Examples of such functional groups include amide bonds, ester bonds, ether bonds, urethane bonds, and urea bonds. From the perspective of highly selective detection of reactants, the functional group is preferably an amide bond.
Y-は、陰イオンであり、例えば、ハロゲンアニオン、ClO4 -、BF4 -、PF6 -、CH3COO-、CF3COO-、及びCH3(C6H4)SO3 -などが挙げられる。 Y − is an anion, and examples thereof include a halogen anion, ClO 4 − , BF 4 − , PF 6 − , CH 3 COO − , CF 3 COO − , and CH 3 (C 6 H 4 )SO 3 − .
上記化学式(1)で表される有機化合物としては、具体的には下記の化合物が挙げられる。
上記化学式(1)で表される有機化合物は、公知の原料及び反応試薬を用いて汎用の化学反応に準じて容易に合成することができる。例えば、上記TMAS及びTMAAは下記の原料及び反応試薬を用いて下記の化学反応により合成することができる。TMAS及びTMAAの詳しい合成法は、実施例において示す。当業者であれば、適切な原料及び反応試薬を用いて汎用の化学反応に準じて、上記TMAS及びTMAA以外の化学式(1)で表される有機化合物についても容易に合成することができるであろう。 The organic compound represented by the above chemical formula (1) can be easily synthesized using known raw materials and reaction reagents in accordance with commonly used chemical reactions. For example, the above TMAS and TMAA can be synthesized by the following chemical reaction using the following raw materials and reaction reagents. Detailed methods for synthesizing TMAS and TMAA are shown in the examples. Those skilled in the art will be able to easily synthesize organic compounds represented by the above chemical formula (1) other than the above TMAS and TMAA in accordance with commonly used chemical reactions using appropriate raw materials and reaction reagents.
上記反応式中、DMT-MM(4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholiniumchloride)は縮合剤であり、TCEP(tris(2-carboxyethyl)phosphine)は還元剤であり、TFAはトリフルオロ酢酸である。 In the above reaction scheme, DMT-MM (4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride) is the condensing agent, TCEP (tris(2-carboxyethyl)phosphine) is the reducing agent, and TFA is trifluoroacetic acid.
上記反応式中、DMT-MM(4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholiniumchloride)は縮合剤であり、Bocはt-ブトキシカルボニル基であり、TFAはトリフルオロ酢酸である。 In the above reaction scheme, DMT-MM (4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride) is a condensing agent, Boc is a t-butoxycarbonyl group, and TFA is trifluoroacetic acid.
本発明の有機化合物は、例えば、微量の化学物質(皮膚感作性物質など)の皮膚感作性評価、及び微量の化学物質の定量的測定に用いることができる。また、本発明の有機化合物は、微量分析の観点から、好ましくは微量の化学物質(皮膚感作性物質など)を検出するための標識試薬、より好ましくは質量分析用標識試薬、更に好ましくは皮膚感作性物質の質量分析用標識試薬として用いることができる。 The organic compound of the present invention can be used, for example, to evaluate the skin sensitization of trace amounts of chemical substances (such as skin sensitizers) and to quantitatively measure trace amounts of chemical substances. Furthermore, from the perspective of trace analysis, the organic compound of the present invention can be used preferably as a labeling reagent for detecting trace amounts of chemical substances (such as skin sensitizers), more preferably as a labeling reagent for mass spectrometry, and even more preferably as a labeling reagent for mass spectrometry of skin sensitizers.
<試薬>
本発明の試薬は、前記有機化合物のみからなるものであってもよく、測定主薬である前記有機化合物の他に1又は2以上の添加剤を含んでいてもよい。添加剤としては、例えば、pH調整剤及び安定化剤などが挙げられる。また、本発明の試薬は、前記有機化合物及び必要に応じて前記添加剤を、水、水性緩衝液、有機溶媒、又はこれらいずれかの混合溶媒に溶解させたものであってもよい。また、本発明の試薬は、溶液、液体状、固体状(粉末、顆粒、凍結乾燥物、錠剤など)のいずれの形態であってもよい。
<Reagents>
The reagent of the present invention may consist solely of the organic compound, or may contain one or more additives in addition to the organic compound as the measurement agent. Examples of additives include pH adjusters and stabilizers. The reagent of the present invention may also be prepared by dissolving the organic compound and, if necessary, the additives in water, an aqueous buffer solution, an organic solvent, or a mixture of these solvents. The reagent of the present invention may be in the form of a solution, liquid, or solid (powder, granules, lyophilized product, tablet, etc.).
本発明の試薬は、例えば、微量の化学物質(皮膚感作性物質など)の皮膚感作性評価、及び微量の化学物質の定量的測定に用いることができる。また、本発明の試薬は、微量分析の観点から、好ましくは微量の化学物質(皮膚感作性物質など)を検出するための標識試薬、より好ましくは質量分析用標識試薬、更に好ましくは皮膚感作性物質の質量分析用標識試薬として用いることができる。 The reagent of the present invention can be used, for example, to evaluate the skin sensitization of trace amounts of chemical substances (such as skin sensitizers) and to quantitatively measure trace amounts of chemical substances. Furthermore, from the perspective of trace analysis, the reagent of the present invention can be used preferably as a labeling reagent for detecting trace amounts of chemical substances (such as skin sensitizers), more preferably as a labeling reagent for mass spectrometry, and even more preferably as a labeling reagent for mass spectrometry of skin sensitizers.
<分析方法>
本発明の分析方法は、前記有機化合物と、化学物質(被験物質)と、を反応させて反応物を得た後、前記反応物を分離し、検出するものである。下記に具体例を挙げて本発明の分析方法を説明する。
<Analysis method>
The analytical method of the present invention involves reacting the organic compound with a chemical substance (test substance) to obtain a reaction product, and then separating and detecting the reaction product. The analytical method of the present invention will be described below with specific examples.
前記化学物質(被験物質)は、前記有機化合物が有するチオール基又はアミノ基に対して反応性を有するもの、あるいは前記有機化合物のチオール基又はアミノ基と反応するものであれば特に制限されないが、好ましくは感作性物質、より好ましくは皮膚感作性物質である。 The chemical substance (test substance) is not particularly limited as long as it is reactive with or reacts with the thiol or amino group of the organic compound, but is preferably a sensitizing substance, more preferably a skin sensitizing substance.
前記有機化合物を含有する試薬は、例えば、酢酸アンモニウムなどの有機酸塩類またはリン酸塩などの無機塩類を含む水性緩衝液、もしくは水又はこれらと有機溶媒との混合溶媒に溶解した混合溶媒緩衝液として用いられる。前記水性緩衝液又は前記混合溶媒緩衝液中の前記有機化合物の濃度は特に制限されないが、例えば、0.01μM~1M程度、通常、0.1mM~500mM程度である。 The reagent containing the organic compound is used, for example, as an aqueous buffer solution containing an organic acid salt such as ammonium acetate or an inorganic salt such as a phosphate, or as a mixed solvent buffer solution in which the organic compound is dissolved in water or a mixed solvent of these with an organic solvent. The concentration of the organic compound in the aqueous buffer solution or mixed solvent buffer solution is not particularly limited, but is, for example, about 0.01 μM to 1 M, typically about 0.1 mM to 500 mM.
前記化学物質(被験物質)は、例えば、メタノール、エタノール、アセトニトリル、アセトンなどの有機溶媒又はこれらの混合溶媒に、例えば、0.01μM~1M程度の濃度、通常、0.1mM~500mM程度の濃度となるように溶解させる。 The chemical substance (test substance) is dissolved in an organic solvent such as methanol, ethanol, acetonitrile, or acetone, or a mixture thereof, to a concentration of, for example, about 0.01 μM to 1 M, typically about 0.1 mM to 500 mM.
次いで、前記試薬を含む前記水性緩衝液又は前記混合溶媒緩衝液と、前記被験物質を含む被験物質溶液とを、前記有機化合物と前記被験物質のモル濃度比が、例えば、1:100~10:1となるように混合し、前記有機化合物と前記被験物質と反応させて反応物を得る。反応は、混合液を、例えば、4℃~60℃程度の温度範囲にて保温しながら、通常、1分~2日間程度撹拌又は静置することにより行うことができる。 The aqueous buffer solution or mixed solvent buffer solution containing the reagent is then mixed with a test substance solution containing the test substance so that the molar concentration ratio of the organic compound to the test substance is, for example, 1:100 to 10:1, and the organic compound is allowed to react with the test substance to obtain a reaction product. The reaction can be carried out by stirring or leaving the mixture to stand, typically for 1 minute to 2 days, while keeping the mixture at a temperature ranging from about 4°C to 60°C.
その後、生成した反応物を分離し、検出する。前記反応物を分離する方法は特に制限されないが、分離性及び検出性に優れる観点から、好ましくはクロマトグラフィーである。前記クロマトグラフィーとしては、例えば、超臨界クロマトグラフィー、イオンクロマトグラフィー、液体クロマトグラフィー、ガスクロマトグラフィー、及び薄層クロマトグラフィーなどが挙げられ、検出性に優れる観点から、好ましくは超臨界クロマトグラフィー、イオンクロマトグラフィー、又は液体クロマトグラフィー、より好ましくは液体クロマトグラフィーである。 The resulting reaction products are then separated and detected. There are no particular limitations on the method for separating the reaction products, but chromatography is preferred from the perspective of excellent separation and detectability. Examples of chromatography include supercritical chromatography, ion chromatography, liquid chromatography, gas chromatography, and thin-layer chromatography. From the perspective of excellent detectability, supercritical chromatography, ion chromatography, or liquid chromatography is preferred, and liquid chromatography is more preferred.
液体クロマトグラフィーとしては、例えば、順相クロマトグラフィー、逆相クロマトグラフィー、サイズ排除クロマトグラフィー、及びイオン交換クロマトグラフィーなどが挙げられ、検出性に優れる観点から、好ましくは逆相クロマトグラフィー又はイオン交換クロマトグラフィー、より好ましくは逆相クロマトグラフィーである。 Examples of liquid chromatography include normal phase chromatography, reverse phase chromatography, size exclusion chromatography, and ion exchange chromatography. From the viewpoint of superior detectability, reverse phase chromatography or ion exchange chromatography is preferred, and reverse phase chromatography is more preferred.
前記反応物の検出方法は特に制限されず、例えば、紫外線、可視線又は赤外線などの分光分析法、質量分析法、蛍光分析法、示差屈折率分析法、電気伝導度分析法、及び蒸発光散乱分析法などが挙げられ、微量分析の観点から、好ましくは質量分析法である。 The method for detecting the reaction product is not particularly limited, and examples include spectroscopic analysis using ultraviolet light, visible light, or infrared light, mass spectrometry, fluorescence analysis, differential refractive index analysis, electrical conductivity analysis, and evaporative light scattering analysis. From the perspective of microanalysis, mass spectrometry is preferred.
前記質量分析法は、質量の分析を利用する分析法であれば特に制限されず、例えば、通常のマススペクトル取得方法;選択イオンモニタリング法;データ依存的取得法、データ非依存的取得法、プリカーサーイオンスキャン法、セレクテッドリアクションモニタリング法、及びコンスタントニュートラルスキャン法などのタンデム質量分析法(MS/MS法)が挙げられ、微量分析の観点から、好ましくはタンデム質量分析法(MS/MS法)である。 The mass spectrometry method is not particularly limited as long as it is an analytical method that utilizes mass analysis, and examples include conventional mass spectrum acquisition methods; selected ion monitoring methods; and tandem mass spectrometry methods (MS/MS methods) such as data-dependent acquisition methods, data-independent acquisition methods, precursor ion scanning methods, selected reaction monitoring methods, and constant neutral scanning methods. From the perspective of trace analysis, tandem mass spectrometry methods (MS/MS methods) are preferred.
MS/MS法としては、例えば、Selected Reaction Monitoring法、Precursor Ion Scan法、及びConstant Neutral Loss Scan法を挙げることができる。MS/MS法に含まれる分析法であれば、今後開発される方法を採用することもできる。 Examples of MS/MS methods include selected reaction monitoring, precursor ion scanning, and constant neutral loss scanning. Methods developed in the future can also be used as long as they are analytical methods included in the MS/MS method.
本発明によれば、皮膚感作性物質などの被験物質を、特定の標識試薬を用いることにより選択性を高めて、簡便、高感度かつ正確に分析することができる。特に、MS/MS法等の質量分析法により被験物質を定量的に分析することができる。また、複数の被験物質を同時に測定することもできる。 According to the present invention, test substances such as skin sensitizers can be analyzed easily, sensitively, and accurately by using specific labeling reagents to enhance selectivity. In particular, test substances can be quantitatively analyzed using mass spectrometry such as MS/MS. Furthermore, multiple test substances can also be measured simultaneously.
本発明の分析方法は、産業上、特に化粧品、日用品、医薬品、及び分析機器の分野において広く利用することができるため極めて有用である。 The analytical method of the present invention is extremely useful because it can be widely used in industry, particularly in the fields of cosmetics, daily necessities, pharmaceuticals, and analytical equipment.
以下、本発明について、実施例に基づき具体的に説明する。 The present invention will now be described in detail with reference to examples.
合成例1
TMAS(4-TriMethylAmmoniobenzoyl 2-Sulfanylethylamine)の合成
1H NMR(D2O):δ7.89(m,4H),3.49(s,9H),2.80(t,2H),2.62(t,2H)
Synthesis Example 1
Synthesis of TMAS (4-TriMethylAmmoniobenzoyl 2-Sulfanylethylamine)
1 H NMR (D 2 O): δ7.89 (m, 4H), 3.49 (s, 9H), 2.80 (t, 2H), 2.62 (t, 2H)
合成例2
TMAA(4-TriMethylAmmoniobenzoyl 6-Aminohexylamine)の合成
合成例1と同様の方法で4-トリメチルアンモニウム安息香酸カリウムを含む水溶液を得た。
1H NMR(D2O):δ7.96(m,4H),3.66(s,9H),3.40(t,2H),2.98(t,2H),1.63(br,4H),1.42(br,2H)
Synthesis Example 2
Synthesis of TMAA (4-TrimethylAmmoniobenzoyl 6-Aminohexylamine) An aqueous solution containing potassium 4-trimethylammonium benzoate was obtained in the same manner as in Synthesis Example 1.
1 H NMR (D 2 O): δ7.96 (m, 4H), 3.66 (s, 9H), 3.40 (t, 2H), 2.98 (t, 2H), 1.63 (br, 4H), 1.42 (br, 2H)
以下の試験例では以下の薬剤を用いた。
(標識試薬)
・TMAS 合成例1で得た化合物
・TMAA 合成例2で得た化合物
・システインペプチド(以下、Cys-Pとも記載)RS synthesis社販売の化合物
・NAC 富士フイルム和光純薬工業よりADRA kitとして入手
(感作性化合物、皮膚感作性:強度)
・過酸化ベンゾイル(分子量242.23)東京化成工業より入手
・ジフェニルシクロプロペノン(分子量206.24)富士フイルム和光純薬工業より入手
・CMI/MI(5-Chloro-2-methyl-4-isothiazolin-3-one/2-methyl-4-isothiazolin-3-one)(皮膚感作性:強度)(CMIの分子量149.59、MIの分子量115.15)Fluorochem社より入手
・シンナムアルデヒド(分子量132.16)富士フイルム和光純薬工業より入手
・トリメリト酸無水物(分子量192.13)富士フイルム和光純薬工業より入手
・p-ベンゾキノン(分子量108.09)富士フイルム和光純薬工業より入手
・ホルムアルデヒド(分子量30.03)ホルムアルデヒド液 富士フイルム和光純薬工業より入手
・オキサゾロン 4-エトキシメチレン-2-フェニルオキサゾリン-5-オン(分子量217.22)富士フイルム和光純薬工業より入手
・塩化パルミトイル(分子量274.87)東京化成工業より入手
なお、上記の皮膚感作性は、前記非特許文献1(G.F.Gerberick et al., Toxicol. Sci., 97(2), 417-427:2007)に記載されたLLNA試験(マウスを用いた試験)による評価結果である。
The following drugs were used in the following test examples.
(Labeling Reagent)
TMAS: Compound obtained in Synthesis Example 1 TMAA: Compound obtained in Synthesis Example 2 Cysteine peptide (hereinafter also referred to as Cys-P): Compound sold by RS Synthesis NAC: Obtained as an ADRA kit from Fujifilm Wako Pure Chemical Industries (sensitizing compound, skin sensitization: strong)
Benzoyl peroxide (molecular weight 242.23) obtained from Tokyo Chemical Industry Co., Ltd. Diphenylcyclopropenone (molecular weight 206.24) obtained from Fujifilm Wako Pure Chemical Industries, Ltd. CMI/MI (5-chloro-2-methyl-4-isothiazolin-3-one/2-methyl-4-isothiazolin-3-one) (skin sensitization: strong) (CMI molecular weight 149 .59, MI molecular weight 115.15) Obtained from Fluorochem. Cinnamaldehyde (molecular weight 132.16) Obtained from Fujifilm Wako Pure Chemical Industries. Trimellitic anhydride (molecular weight 192.13) Obtained from Fujifilm Wako Pure Chemical Industries. p-Benzoquinone (molecular weight 108.09) Obtained from Fujifilm Wako Pure Chemical Industries. Formaldehyde (molecular weight 30.03) Formaldehyde liquid Obtained from Fujifilm Wako Pure Chemical Industries, Ltd.; Oxazolone 4-ethoxymethylene-2-phenyloxazolin-5-one (molecular weight 217.22) obtained from Fujifilm Wako Pure Chemical Industries, Ltd.; Palmitoyl chloride (molecular weight 274.87) obtained from Tokyo Chemical Industry Co., Ltd. The above skin sensitization is an evaluation result by the LLNA test (a test using mice) described in the aforementioned Non-Patent Document 1 (GF Gerberick et al., Toxicol. Sci., 97(2), 417-427:2007).
試験例1:感作性化合物との反応物の検出感度評価
(1)TMASについて(本発明)
[TMAS溶液の調製]
TMAS(分子量337.38)を12.5mg秤量して、100mMリン酸(ナトリウム)緩衝液(pH=8.0)を加えて溶解し、100mLに定容した(125mg/L溶液)。
Test Example 1: Evaluation of detection sensitivity of reaction products with sensitizing compounds (1) TMAS (present invention)
[Preparation of TMAS solution]
12.5 mg of TMAS (molecular weight 337.38) was weighed out and dissolved in 100 mM phosphate (sodium) buffer (pH = 8.0), and the volume was adjusted to 100 mL (125 mg/L solution).
(2)Cys-Pについて(比較例)
[Cys-P溶液の調製]
前記非特許文献1(G.F.Gerberick et al., Toxicol. Sci., 97(2), 417-427:2007)に記載されたシステインペプチド(Ac-Arg-Phe-Ala-Ala-Cys-Ala-Ala-COOH:以下Cys-P)(分子量750.87)を12.5mg秤量して、100mMリン酸(ナトリウム)緩衝液(pH=8.0)を加えて溶解し、100mLに定容した(125mg/L溶液)。
(2) Cys-P (Comparative Example)
[Preparation of Cys-P solution]
12.5 mg of the cysteine peptide (Ac-Arg-Phe-Ala-Ala-Cys-Ala-Ala-COOH: hereinafter referred to as Cys-P) (molecular weight: 750.87) described in Non-Patent Document 1 (GF Gerberick et al., Toxicol. Sci., 97(2), 417-427:2007) was weighed out and dissolved in 100 mM phosphate (sodium) buffer (pH = 8.0), and the volume was adjusted to 100 mL (125 mg/L solution).
(3)NACについて(比較例)
[NAC溶液の調製]
前記特許文献2(特開2011-59102号公報)に記載されたN-(2-(1-naphthyl)acetyl)-L-cysteine(以下、NACともいう)(分子量289.34)が14.5μg含まれる試薬瓶に対して、100mMリン酸(ナトリウム)緩衝液(pH=8.0)を1mL加えて溶解した(14.5mg/L溶液)。
(3) NAC (Comparative Example)
[Preparation of NAC solution]
To a reagent bottle containing 14.5 μg of N-(2-(1-naphthalyl)acetyl)-L-cysteine (hereinafter also referred to as NAC) (molecular weight: 289.34) described in Patent Document 2 (JP 2011-59102 A), 1 mL of 100 mM phosphate (sodium) buffer (pH = 8.0) was added and dissolved (14.5 mg/L solution).
[反応液の調製方法]
1ml用バイアル瓶にTMAS、Cys-P又はNAC125mg/L溶液600μlと被験物質(シンナムアルデヒド)の50μg/Lおよび5000μg/Lアセトニトリル溶液150μlを添加して撹拌した(水/溶媒=80/20)。この混合液を24時間、室温で反応させた後に以下に記載の条件にてHPLCに供した。
[Method for preparing reaction solution]
600 μL of a 125 mg/L solution of TMAS, Cys-P, or NAC and 150 μL of a 50 μg/L or 5000 μg/L acetonitrile solution of the test substance (cinnamaldehyde) were added to a 1 mL vial and stirred (water/solvent = 80/20). This mixture was reacted at room temperature for 24 hours and then subjected to HPLC under the conditions described below.
[HPLC測定条件]
装置:Agilent 1290 Series(Agilent製)、TripleTOF 6600(Sciex製)
カラム:Kinetex polar C18(2.1mm×150mm、2.6μm)
カラム温度:40℃
流速:0.15ml/min.
検出:ESI(+)
検出方法:High Resolution Multiple Reaction Monitoring
測定質量範囲:MS(反応生成物に依存)、MS/MS(m/z 100-1000)
溶離液A:超純水(0.1%ギ酸)
溶離液B:アセトニトリル(0.1%ギ酸)
溶出条件:下記グラジエント
分析時間:30分間
[HPLC measurement conditions]
Apparatus: Agilent 1290 Series (manufactured by Agilent), TripleTOF 6600 (manufactured by Sciex)
Column: Kinetex polar C18 (2.1 mm x 150 mm, 2.6 μm)
Column temperature: 40°C
Flow rate: 0.15ml/min.
Detection: ESI (+)
Detection method: High Resolution Multiple Reaction Monitoring
Measurement mass range: MS (depending on reaction product), MS/MS (m/z 100-1000)
Eluent A: Ultrapure water (0.1% formic acid)
Eluent B: acetonitrile (0.1% formic acid)
Elution conditions: gradient as follows
Analysis time: 30 minutes
[測定結果]
各クロマトグラムを図1に示す。被験物質50μg/Lの測定結果により、それぞれのS/N比を比較すると、TMASはおよそ60、Cys-PおよびNACは非検出であった。被験物質5000μg/Lの測定結果により、それぞれのS/N比を比較すると、TMASはおよそ6000、Cys-Pはおよそ20、NACはおよそ110であり、TMASはCys-PやNACに比べて数十倍から数百倍程度高感度に検出できることが分かった。
[Measurement results]
The chromatograms are shown in Figure 1. Comparing the S/N ratios of the test substance at 50 μg/L, TMAS was approximately 60, while Cys-P and NAC were not detected. Comparing the S/N ratios of the test substance at 5000 μg/L, TMAS was approximately 6000, Cys-P was approximately 20, and NAC was approximately 110, demonstrating that TMAS can be detected with sensitivity several tens to several hundreds times higher than that of Cys-P or NAC.
試験例2:感作性化合物との反応性と、反応物の検出感度評価
[被験物質]
感作性化合物として表3に記載の化合物を使用して、以下に記載の方法に従って皮膚感作性の測定を行った。
Test Example 2: Evaluation of reactivity with sensitizing compounds and detection sensitivity of reaction products
[Test substance]
Using the compounds shown in Table 3 as sensitizing compounds, skin sensitization was measured according to the method described below.
(1)TMASについて(本発明)
[TMAS溶液の調製]
前記試験例1と同様の方法でTMAS溶液を調製した。
(1) About TMAS (the present invention)
[Preparation of TMAS solution]
A TMAS solution was prepared in the same manner as in Test Example 1.
[反応液の調製方法]
前記試験例1と同様の方法で反応液を調製した。
[Method for preparing reaction solution]
A reaction solution was prepared in the same manner as in Test Example 1 above.
[HPLC測定条件]
装置:Agilent 1290 Series(Agilent製)、TripleTOF 6600(Sciex製)
カラム:Kinetex polar C18(2.1mm×150mm、2.6μm)
カラム温度:40℃
流速:0.25ml/min.
検出:ESI(+)m/z 70-1300
検出方法: Information Dependent Acquisition
測定質量範囲:TOF MS(m/z 70-1300)、MS/MS(m/z 70-1300)
溶離液A:超純水(0.1%ギ酸)
溶離液B:アセトニトリル(0.1%ギ酸)
溶出条件:下記グラジエント
Apparatus: Agilent 1290 Series (manufactured by Agilent), TripleTOF 6600 (manufactured by Sciex)
Column: Kinetex polar C18 (2.1 mm x 150 mm, 2.6 μm)
Column temperature: 40°C
Flow rate: 0.25ml/min.
Detection: ESI (+) m / z 70-1300
Detection Method: Information Dependent Acquisition
Measurement mass range: TOF MS (m/z 70-1300), MS/MS (m/z 70-1300)
Eluent A: Ultrapure water (0.1% formic acid)
Eluent B: acetonitrile (0.1% formic acid)
Elution conditions: gradient as follows
S/N比を算出し、S/N比3を検出限界としてその濃度(μg/L)を求めた。結果を表3に示す。 The S/N ratio was calculated, and the concentration (μg/L) was determined with an S/N ratio of 3 as the detection limit. The results are shown in Table 3.
試験例3:感作性化合物との反応性と、反応物の検出感度評価
[被験物質]
感作性化合物として表4に記載された化合物を使用して、以下に記載の方法に従って皮膚感作性の測定を行った。
(2)TMAAについて(本発明)
[TMAA溶液の調製]
TMAA(分子量505.46)を12.5mg秤量して、100mMリン酸(ナトリウム)緩衝液(pH=10.2)を加えて溶解し、100mLに定容した(125mg/L溶液)。
Test Example 3: Evaluation of reactivity with sensitizing compounds and detection sensitivity of reaction products
[Test substance]
Using the compounds shown in Table 4 as sensitizing compounds, skin sensitization was measured according to the method described below.
(2) TMAA (the present invention)
[Preparation of TMAA solution]
12.5 mg of TMAA (molecular weight 505.46) was weighed out and dissolved in 100 mM phosphate (sodium) buffer (pH = 10.2), and the volume was adjusted to 100 mL (125 mg/L solution).
[反応液の調製方法]
前記試験例1と同様の方法で反応液を調製した。
[Method for preparing reaction solution]
A reaction solution was prepared in the same manner as in Test Example 1 above.
[HPLC測定条件]
前記試験例1と同じ。
[HPLC measurement conditions]
Same as Test Example 1.
S/N比を算出し、S/N比3を検出限界としてその濃度(μg/L)を求めた。結果を表4に示す。 The S/N ratio was calculated, and the concentration (μg/L) was determined using an S/N ratio of 3 as the detection limit. The results are shown in Table 4.
本発明の有機化合物、試薬、及び分析方法は、微量の化学物質の皮膚感作性評価、及び微量の化学物質の定量的測定に好適に用いられる。 The organic compounds, reagents, and analytical methods of the present invention are suitable for use in evaluating the skin sensitization potential of trace amounts of chemical substances and for quantitatively measuring trace amounts of chemical substances.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021205820A JP7808465B2 (en) | 2021-12-20 | 2021-12-20 | Organic compounds, reagents, and analytical methods |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021205820A JP7808465B2 (en) | 2021-12-20 | 2021-12-20 | Organic compounds, reagents, and analytical methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023091200A JP2023091200A (en) | 2023-06-30 |
| JP7808465B2 true JP7808465B2 (en) | 2026-01-29 |
Family
ID=86941192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021205820A Active JP7808465B2 (en) | 2021-12-20 | 2021-12-20 | Organic compounds, reagents, and analytical methods |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7808465B2 (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005537223A (en) | 2002-04-05 | 2005-12-08 | ニトロメッド,インク. | Nitric oxide donors, compositions and methods of use |
| JP2008531702A (en) | 2005-02-28 | 2008-08-14 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス, インコーポレイテッド | Semi-synthetic glycopeptide with antibacterial activity |
| JP2011059102A (en) | 2009-08-13 | 2011-03-24 | Fujifilm Corp | Skin sensitization measuring reagent |
| JP2014037995A (en) | 2012-08-13 | 2014-02-27 | Fujifilm Corp | Skin sensitization measuring reagent |
| JP2015524058A (en) | 2012-05-22 | 2015-08-20 | バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. | Capture agents for screening reactive metabolites |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB951667A (en) * | 1961-04-25 | 1964-03-11 | Ici Ltd | New water soluble azo dyestuffs containing quaternary ammonium groups |
| JPS49118721A (en) * | 1973-03-19 | 1974-11-13 | ||
| DE2315637A1 (en) * | 1973-03-29 | 1974-10-03 | Bayer Ag | CATIONIC AZO DYES |
| US4973475A (en) * | 1988-10-07 | 1990-11-27 | Revlon, Inc. | Hair treatment and conditioning agents |
-
2021
- 2021-12-20 JP JP2021205820A patent/JP7808465B2/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005537223A (en) | 2002-04-05 | 2005-12-08 | ニトロメッド,インク. | Nitric oxide donors, compositions and methods of use |
| JP2008531702A (en) | 2005-02-28 | 2008-08-14 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス, インコーポレイテッド | Semi-synthetic glycopeptide with antibacterial activity |
| JP2011059102A (en) | 2009-08-13 | 2011-03-24 | Fujifilm Corp | Skin sensitization measuring reagent |
| JP2015524058A (en) | 2012-05-22 | 2015-08-20 | バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. | Capture agents for screening reactive metabolites |
| JP2014037995A (en) | 2012-08-13 | 2014-02-27 | Fujifilm Corp | Skin sensitization measuring reagent |
Non-Patent Citations (6)
| Title |
|---|
| Biochimica et Biophysica Acta, Enzymology,1972年,Vol.268,pp.138-157 |
| Chemical Communications,2015年,Vol.51,pp.11052-11055 |
| Chemical Communications,2015年,Vol.51,pp.14247-14250 |
| European Journal of Medicinal Chemistry,2009年,Vol.44,pp.717-724 |
| Hoppe-Seyler's Zeitschrift fuer Physiologische Chemie,1978年,Vol.359,pp.1783-1795 |
| Textile Research Journal,Vol.71, No.8,2001年,pp.695-700 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023091200A (en) | 2023-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7055267B2 (en) | Analytical methods and reagents for amino functional compounds | |
| EP0533200B1 (en) | Preparation and use of novel activated carbamates | |
| Fitch et al. | Chemiluminescent nitrogen detection for HPLC: an important new tool in organic analytical chemistry | |
| Li et al. | A rapid and sensitive method for chiroptical sensing of α-amino acids via click-like labeling with o-phthalaldehyde and p-toluenethiol | |
| JP5997543B2 (en) | Reagent for skin sensitization | |
| CN114486835B (en) | Cholesterol chiral molecular clamp for rapid detection of tryptophan in food | |
| CN108101793B (en) | Compound and competitive fluorescence detection method of compound applied to amantadine compound | |
| JP7808465B2 (en) | Organic compounds, reagents, and analytical methods | |
| WO2022085762A1 (en) | Reagent for measuring skin sensitization, compound, and method for measuring skin sensitization | |
| CN111796039B (en) | Liquid chromatography calibration method for rapidly-labeled N-glycan | |
| US20060240455A1 (en) | Oxazine derivatives | |
| Liu et al. | Fluorescence enhanced sensing of cysteine based on reactive probe of naphthalene-quinoline | |
| Li et al. | A Rapid and Sensitive Method for Chiroptical Sensing of a-Amino Acids via Click-like Labeling with o-Phthaladehyde and p-Toluenethiol | |
| WO2021060477A1 (en) | Reagent for measuring skin sensitization, method for measuring skin sensitization, and compound | |
| JP7372145B2 (en) | Method for quantifying surface-bound amino groups | |
| JP4616194B2 (en) | Biotin compound | |
| JP2001242174A (en) | Histamine or histidine analysis method | |
| CN109387588A (en) | The separation method of water soluble ultraviolet absorbent and its application | |
| Sonoki et al. | High-Performance Liquid Chromatographic Analysis of 2′-Deoxynucleoside 5′-Monophosphate Using N-(Dansyl) Ethylenediamine as a Fluorescent Derivatizing Reagent | |
| CN121164485A (en) | Method for simultaneously detecting contents of L-homoserine and L-homoserine lactone hydrochloride by ion chromatography | |
| CN110658163A (en) | Method for monitoring reaction in synthesis of DNA coding compound | |
| Gober | Design and Application of Synthetic Receptors for Recognition of Methylated Lysine and Supramolecular Affinity Labeling | |
| JP2008094801A (en) | Fluorescent compound and method for topological analysis of protein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240905 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250527 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20250529 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250708 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250715 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20251009 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251020 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20260106 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20260119 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7808465 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |